文献速递湿疹皮炎与荨麻疹

欧洲五国成人特应性皮炎的疾病负担:2016年国家健康与健康调查分析

Burden of illness in adults with atopic dermatitis: Analysis of National Health and Wellness Survey data from France, Germany, Italy, Spain, and the United Kingdom.
PubMed 文献 · J Am Acad Dermatol · 2019-03-21

本研究基于2016年法国、德国、意大利、西班牙和英国的全国健康与健康调查数据,对自我报告的特应性皮炎(AD)患者与无AD的匹配对照(各1860例)进行比较。结果显示,AD患者及控制不佳的AD亚组在健康相关生活质量、焦虑、抑郁、睡眠障碍、工作效率和活动受损、急诊和临床就诊等方面均显著高于对照,且控制不佳者负担更重。

要点

  • 成人AD患者焦虑、抑郁和睡眠障碍患病率显著高于无AD对照。
  • 控制不佳的AD患者工作效率和活动受损、急诊就诊比例更高。
  • AD对健康相关生活质量、生产力和医疗资源使用造成显著负担。

核心结论

  • 成人AD患者在健康、健康相关生活质量、生产力、活动和医疗保健方面报告了显著负担。

研究设计与样本

  • 数据来自2016年在法国、德国、意大利、西班牙和英国开展的国家健康与健康调查。
  • 对自我报告AD患者与无AD的匹配对照(各n=1860)进行双变量分析。

主要发现

  • AD患者与控制不佳AD亚组分别报告焦虑患病率31.9%和51.7%,对照为14.4%(P<.001)。
  • AD患者与控制不佳AD亚组分别报告抑郁患病率25.8%和36.2%,对照为12.9%(P<.001)。
  • AD患者与控制不佳AD亚组分别报告睡眠障碍患病率22.7%和39.7%,对照为12.6%(P<.001)。
  • 控制不佳AD患者总体工作受损57.1%、活动受损51.7%,对照分别为23.7%和26.5%(P<.001)。
  • AD患者中21.6%、控制不佳AD患者中37.9%报告过去6个月至少1次急诊就诊,对照为16.5%;AD患者93.1%至少1次临床就诊,对照84.2%(均P<.001)。

临床怎么用

  • 临床应关注成人AD患者的焦虑、抑郁和睡眠障碍筛查与管理。
  • 对控制不佳的AD患者需重视其工作生产力下降和医疗资源使用增加。

局限性

  • 回应率低。
  • 调查技术可及性可能导致选择偏倚。
  • 患者报告数据易受回忆偏倚影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The disease burden of atopic dermatitis (AD) in European populations is not well known. OBJECTIVE: To establish the disease burden in European adult patients with AD. METHODS: Data were from the 2016 National Health and Wellness Survey conducted in France, Germany, Italy, Spain, and the United Kingdom. Bivariate analyses were conducted on outcomes between controls without AD matched to patients with self-reported AD (both n = 1860). RESULTS: Patients with AD and a subset of patients with inadequately controlled AD (IC-AD) versus controls without AD, respectively, reported significantly higher (P < .001) 36-Item Short Form Health Survey Physical and Mental Component Summaries (PCS, MCS), and anxiety (31.9% and 51.7% vs 14.4%), depression (25.8% and 36.2% vs 12.9%), and sleep disorder (22.7% and 39.7% vs 12.6%) prevalences. Patients with IC-AD versus controls without AD reported significantly greater (P < .001) overall work (57.1% vs 23.7%) and activity impairment (51.7% vs 26.5%). In addition, 21.6% of patients with AD and 37.9% of patients with IC-AD reported ≥1 emergency department visit in the previous 6 months versus 16.5% of controls without AD, and 93.1% of patients with AD versus 84.2% of those without AD had ≥1 clinician visit (both P < .001). Of these, patients with IC-AD showed greater burden on most outcomes than patients with controlled AD. LIMITATIONS: Low response rate, possible selection bias due to survey technology availability, and patient-reported data susceptible to recall bias. CONCLUSION: Patients with AD reported significant burden on health, health-related quality of life, productivity, activities, and health care.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Eckert L, Gupta S, Gadkari A, et al. Burden of illness in adults with atopic dermatitis: Analysis of National Health and Wellness Survey data from France, Germany, Italy, Spain, and the United Kingdom. J Am Acad Dermatol. 2019. PMID: 30905805. doi:10.1016/j.jaad.2019.03.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。